Sample size calculation in hierarchical
coefficient of variation
controlled effect
interaction test
linear mixed model
marginal effect
power analysis
Journal
Statistics in medicine
ISSN: 1097-0258
Titre abrégé: Stat Med
Pays: England
ID NLM: 8215016
Informations de publication
Date de publication:
20 02 2022
20 02 2022
Historique:
revised:
19
11
2021
received:
04
02
2021
accepted:
25
11
2021
pubmed:
4
1
2022
medline:
1
4
2022
entrez:
3
1
2022
Statut:
ppublish
Résumé
Motivated by a suicide prevention trial with hierarchical treatment allocation (cluster-level and individual-level treatments), we address the sample size requirements for testing the treatment effects as well as their interaction. We assume a linear mixed model, within which two types of treatment effect estimands (controlled effect and marginal effect) are defined. For each null hypothesis corresponding to an estimand, we derive sample size formulas based on large-sample z-approximation, and provide finite-sample modifications based on a t-approximation. We relax the equal cluster size assumption and express the sample size formulas as functions of the mean and coefficient of variation of cluster sizes. We show that the sample size requirement for testing the controlled effect of the cluster-level treatment is more sensitive to cluster size variability than that for testing the controlled effect of the individual-level treatment; the same observation holds for testing the marginal effects. In addition, we show that the sample size for testing the interaction effect is proportional to that for testing the controlled or the marginal effect of the individual-level treatment. We conduct extensive simulations to validate the proposed sample size formulas, and find the empirical power agrees well with the predicted power for each test. Furthermore, the t-approximations often provide better control of type I error rate with a small number of clusters. Finally, we illustrate our sample size formulas to design the motivating suicide prevention factorial trial. The proposed methods are implemented in the R package H2x2Factorial.
Identifiants
pubmed: 34978097
doi: 10.1002/sim.9284
pmc: PMC8962918
mid: NIHMS1763126
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
645-664Subventions
Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States
Informations de copyright
© 2022 John Wiley & Sons Ltd.
Références
Psychiatr Serv. 2013 Dec 1;64(12):1195-202
pubmed: 24036589
J Stat Plan Inference. 2018 Mar;194:106-121
pubmed: 29358843
Biometrics. 2020 Dec;76(4):1064-1074
pubmed: 31872435
Int J Epidemiol. 2006 Oct;35(5):1292-300
pubmed: 16943232
Stat Med. 2005 Sep 15;24(17):2583-96
pubmed: 16118812
Stat Med. 2007 Jun 15;26(13):2589-603
pubmed: 17094074
Stat Med. 2020 Dec 10;39(28):4218-4237
pubmed: 32823372
J Am Acad Child Adolesc Psychiatry. 2009 Oct;48(10):1005-1013
pubmed: 19730273
Stat Med. 2016 Oct 30;35(24):4320-4334
pubmed: 27271007
Biometrics. 2018 Dec;74(4):1450-1458
pubmed: 29921006
Am J Prev Med. 2014 Oct;47(4):498-504
pubmed: 25092122
Trials. 2016 Feb 09;17:72
pubmed: 26862034
Stat Med. 2001 Feb 15;20(3):377-90
pubmed: 11180308
BMC Med Res Methodol. 2015 Apr 23;15:38
pubmed: 25899170
Stat Med. 2010 Jun 30;29(14):1488-501
pubmed: 20101669
BMC Med Res Methodol. 2003 Nov 24;3:26
pubmed: 14633287
J Clin Epidemiol. 2014 Oct;67(10):1083-92
pubmed: 25063555
Pilot Feasibility Stud. 2019 Oct 10;5:115
pubmed: 31624637
JAMA. 2003 May 21;289(19):2545-53
pubmed: 12759326
Eur Heart J. 1994 May;15(5):585-8
pubmed: 8055995
BMJ. 2011 Sep 26;343:d5886
pubmed: 21948873
Eval Rev. 2003 Feb;27(1):79-103
pubmed: 12568061
J Clin Epidemiol. 2018 Apr;96:120-125
pubmed: 29113938
Am J Public Health. 2017 Jul;107(7):1078-1086
pubmed: 28520480
Stat Med. 2018 Jan 15;37(1):12-27
pubmed: 28948651
Psychol Methods. 2012 Jun;17(2):153-75
pubmed: 22309956
Stat Med. 2007 Mar 15;26(6):1181-92
pubmed: 16927251
J Clin Epidemiol. 2020 Jan;117:52-59
pubmed: 31585174
Stat Med. 2010 Sep 20;29(21):2169-79
pubmed: 20687162